Middle Eastern Penny Stocks: 3 Picks With Market Caps Under US$500M

Simply Wall St

Wed, Jul 16, 2025, 12:04 AM 4 min read

Most Gulf bourses have recently seen an upswing, buoyed by favorable U.S. economic data and ongoing trade discussions, which has injected a dose of optimism into the Middle Eastern markets. Despite being associated with earlier market periods, penny stocks continue to offer intriguing opportunities for investors willing to explore smaller or emerging companies. These stocks can present a compelling mix of affordability and growth potential when backed by strong financials, making them an interesting area for those seeking value in the Middle East’s dynamic market landscape.

Click here to see the full list of 75 stocks from our Middle Eastern Penny Stocks screener.

Let’s dive into some prime choices out of the screener.

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Gulf Pharmaceutical Industries P.S.C., also known as Julphar, manufactures and sells a range of pharmaceutical, cosmetic, and medical products in the UAE, other GCC countries, and internationally with a market cap of AED1.72 billion.

Operations: Julphar’s revenue is primarily derived from its Manufacturing segment, which generated AED864.9 million, while the Planet segment contributed AED732.9 million.

Market Cap: AED1.72B

Gulf Pharmaceutical Industries P.S.C., known as Julphar, has shown significant financial improvement, reporting AED 359.2 million in sales for the first quarter of 2025 and a net income surge to AED 140.9 million from AED 1.9 million a year ago. Despite its low Return on Equity of 2.4%, Julphar’s debt is well managed with a satisfactory net debt to equity ratio of 4.8%. The company’s earnings growth is notable, although its share price remains highly volatile compared to other stocks in the region. Recent management changes include appointing KPMG as external auditors for the year ahead.

• Get an in-depth perspective on Gulf Pharmaceutical Industries P.S.C’s performance by reading our balance sheet health report here.

• Evaluate Gulf Pharmaceutical Industries P.S.C’s prospects by accessing our earnings growth report.